Samenvatting
‘Harm reduction’-strategieën blijken effectief, zo leert internationaal onderzoek. Essentieel is dat een lokaal drugsbeleid, waar harm reduction een pijler van uitmaakt, is afgestemd op de lokale setting en de lokale behoeften. Bij de uitbouw van een drugsbeleid is het dan ook noodzakelijk om alle betrokken actoren een stem te geven. Deze insteek was het startpunt van deze studie, waarbij de lokale behoeften van zowel professionals als drugsgebruikers in kaart werden gebracht wat betreft harm reduction. De resultaten tonen aan dat de prioriteiten van beide groepen respondenten gelijkenissen vertonen, maar ook aanzienlijke verschillen. Dit bevestigt het belang om, binnen een ‘bottom-up’-aanpak, ook drugsgebruikers als sleutelfiguren te includeren in beleids- en praktijkgericht onderzoek.
Abstract
Internationally, harm reduction programmes are widely considered effective tools for addressing drug-related harms. Essentially, a local drug policy, of which harm reduction constitutes one pillar, is adequately tailored to the needs of the community. In developing such a drug policy, involvement of all relevant stakeholders is imperative. This constituted the starting point of this study, in which professionals’ and drug users’ local harm reduction needs were identified. Results indicate some consensus between priorities between both groups of respondents, but also important discrepancies. This confirms the importance to include drug users’ views in policy and practice research, as a necessary complement to professionals’ perspectives.
Notes
Het Drugbeleidsplan Stad Gent (2013–2018) heeft ‘gezondheidsbevordering van drugsgebruikers - harm reduction’ als een van de zeven speerpunten opgenomen. De overige speerpunten zijn: a sociale activering en arbeidsactivering drugsgebruikers, b bestrijding drugsoverlast, c aandacht voor dubbele diagnose, d alcoholbeleid, e veilig en gezond uitgaan, en f gerichte preventie/vroeginterventie/opvoedingsondersteuning bij minder bereikte groepen.
Gebruiksruimtes kunnen we globaal onderverdelen in twee types. Specifieke gebruiksruimtes functioneren volledig op zichzelf en autonoom. Geïntegreerde gebruiksruimtes maken deel uit van een breder netwerk van voorzieningen; ze zijn vaak op dezelfde locatie als andere laagdrempelige drugshulpverleningscentra gevestigd (Havinga et al. 2012).
Literatuur
Blanken, P., Vollemans, L., Verveen, J., Hendriks, V., & Adriaans, N. (1995). Perron Nul en de bezoekers die er kwamen. Het Rotterdams Drug Monitoring Systeem, 1994. Den Haag: IVO.
Chorlton, E., Smith, I., & Jones, S. (2015). Understanding how people who use illicit drugs and alcohol experience relationships with psychiatric inpatient staff. Social Psychiatry and Psychiatric Epidemiology, 50, 51–58.
Davies, R., Heslop, P., Onyett, S., & Soteriou, T. (2014). Effective support for those who are ‘hard to engage’: a qualitative user-led study. Journal of Mental Health, 23, 62–66.
Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., & Hickman, M. (2010). HIV prevention for people who inject drugs: Why individual, structural, and combination approaches are required. Lancet, 376, 285–301.
De Maeyer, J., Dekkers, A., & Vanderplasschen, W. (2012). Kwaliteit van leven: ‘onder invloed’ van methadon. Verslaving, 8, 45–58.
De Maeyer, J., Nieuwenhuizen, C. van., Bongers, I. L., Broekaert, E., & Vanderplasschen, W. (2013). Profiles of quality of life in opiate-dependent individuals after starting methadone treatment: a latent class analysis. International Journal of Drug Policy, 24, 342–350.
Decorte, T., & Janssen, K. (2011). Antwerpse Drug- en Alcoholmonitor. Een lokale drugscene in beeld. Resultaten 2010. Antwerpen: SODA.
Demaret, I., Herné, P., Lemaître, A., & Ansseau, M. (2011). Feasibility assessment of heroin-assisted treatment in Liège, Belgium. Acta Psychiatrica Belgica, 111, 3–8.
Demaret, I., Litran, G., Magoga, C., Deblire, C., De Roubaix, J., Quertemont, E., Van Caillie, D., Dubois, N., Lemaître, A., & Ansseau, M. (2013). Project TADAM. Eindrapport 2007–2013. Liège: Université de Liège.
EMCDDA. (2015). Drugs policy and the city in Europe. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
Farrelly, S., Brown, G., Rose, D., Doherty, E., Henderson, C., Birchwood, M., Marshall, M., Waheer, W., Szmukler, G., & Thornicroft, G. (2014). What service users with psychotic disorders want in a mental health crisis or relapse: Thematic analysis of joint crisis plans. Social Psychiatry and Psychiatric Epidemiology, 49, 1609–1617.
Favril, L., Vander Laenen, F., & Decorte, T. (2015). Schadebeperkende maatregelen voor de stad Gent. Een onderzoek naar de lokale noden en prioriteiten. Antwerpen: Maklu.
Glasby, J., & Beresford, P. (2006). Who knows best? Evidence-based practice and the service user contribution. Critical Social Policy, 26, 268–284.
Havinga, P., & Poel, A. van der. (2012). Organisatie en inrichting van gebruiksruimten in Nederland (2003–2010). Verslaving, 8, 44–54.
IHRA. (2010). What is harm reduction? A position statement from the International Harm Reduction Association. Londen: International Harm Reduction Association.
Korf, D. J., & Steenhoven, P. van der (1994). Antenne 1993. Trends in alcohol, tabak, drugs en gokken bij jonge Amsterdammers. Amsterdam: Jellinek.
Krug, A., Hildebrand, M., & Sun, N. (2015). ‘We don’t need services. We have no problems’: Exploring the experiences of young people who inject drugs in accessing harm reduction services. Journal of the International AIDS Society, 18, 71–77.
Lancaster, K., Ritter, A., & Stafford, J. (2013). Public opinion and drug policy in Australia: engaging the ‘affected community’. Drug and Alcohol Review, 32, 60–66.
Lancaster, K., Sutherland, R., & Ritter, A. (2014). Examining the opinions of people who use drugs towards drug policy in Australia. Drugs: Education, Prevention and Policy, 21, 93–101.
MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ, 345, e5945.
Marlatt, G. A., & Witkiewitz, K. (2010). Update on harm-reduction policy and intervention research. Annual Review of Clinical Psychology, 6, 591–606.
McCann, E. J. (2008). Expertise, truth, and urban policy mobilities: Global circuits of knowledge in the development of Vancouver, Canada’s ‘four pillar’ drug strategy. Environment and Planning, 40, 885–904.
Mheen, D. van de. (2000). De Rotterdamse drugsscene onder de loep. Resultaten van vijf jaar Drug Monitoring Systeem in Rotterdam. Rotterdam: IVO.
Mortelmans, D. (2010). Het kwalitatief onderzoeksdesign. In Decorte, T., & Zaitch, D. (Eds.), Kwalitatieve methoden en technieken in de criminologie (S. 75–118). Leuven: Acco.
Owczarzak, J., Dickson-Gomez, J., Convey, M., & Weeks, M. (2013). What is ‘support’ in supportive housing: client and service providers’ perspectives. Human Organization, 72, 254–262.
Palmateer, N., Kimber, J., Hickman, M., Hutchinson, S., Rhodes, T., & Goldberg, D. (2010). Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction, 105, 844–859.
Parker, J., Jackson, L., Dykeman, M., Gahagan, J., & Karabanow, J. (2012). Access to harm reduction services in Atlantic Canada: implications for non-urban residents who inject drugs. Health and Place, 18, 152–162.
Ponsaers, P., De Ruyver, B., Lemaître, A., Macquet, C., Pieters, T., Vaerewyck, W., Fincoeur, B., & Vander Laenen, F. (2005). Drugoverlast in de lokale context van acht Vlaamse en Waalse gemeenten. Gent: Academia Press.
Ponsaers, P., De Ruyver, B., Lemaître, A., Macquet, C., Bucquoye, A., Surmont, T., & Simays, C. (2006). Monitor integraal lokaal drugbeleid. Brussel: Federaal Wetenschapsbeleid.
Potier, C., Laprévote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014). Supervised injection services: what has been demonstrated? A systematic literature review. Drug and Alcohol Dependence, 145, 48–68.
Pulford, J., Adams, P., & Sheridan, J. (2009). Client/clinician discrepancies in perceived problem improvement and the potential influence on dropout response. International Journal of Mental Health and Addiction, 7, 497–505.
Rance, J., & Treloar, C. (2015). ‘We are people too’: Consumer participation and the potential transformation of therapeutic relations within drug treatment. International Journal of Drug Policy, 26, 30–36.
Rhodes, T., & Hedrich, D. (2010). Harm reduction: evidence, impacts and challenges. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
Ritter, A., & Cameron, J. (2006). A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25, 611–624.
Roy, A. (2012). Avoiding the involvement overdose: drugs, race, ethnicity and participatory research practice. Critical Social Policy, 32, 636–654.
Smye, V., Browne, A. J., Varcoe, C., & Josewski, V. (2011). Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: an intersectional lens in the Canadian context. Harm Reduction Journal, 8, 17.
Strang, J., Babor, T., Caulkins, J., Fischer, B., Foxcroft, D., & Humphreys, K. (2012). Drug policy and the public good: evidence for effective interventions. Lancet, 379, 71–83.
Strang, J., Groshkova, T., Uchtenhagen, A., Brink, W. van den., Haasen, C., Schechter, M. T., Lintzeris, N., Bell, J., Pirona, A., Oviedo-Joekes, E., Simon, R., & Metrebian, N. (2015). Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. British Journal of Psychiatry, 207, 5–14.
Strike, C., Jairam, J. A., Kolla, G., Millson, P., Shepherd, S., Fischer, B., Watson, T. M., & Bayoumi, A. M. (2014). Increasing public support for supervised injection facilities in Ontario, Canada. Addiction, 109, 946–953.
Sumnall, H., & Brotherhood, A. (2012). Social reintegration and employment: evidence and interventions for drug users in treatment. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
Ti, L., Tzemis, D., & Buxton, J. A. (2012). Engaging people who use drugs in policy and program development: a review of the literature. Substance Abuse Treatment, Prevention, and Policy, 7, 47.
Tieberghien, J. (2009). Antwerpse Drug- en Alcoholmonitor (ADAM). Verslaving, 5, 3–19.
Tieberghien, J., & Decorte, T. (2009). Antwerp Drugs and Alcohol Monitor: a Belgian local drug scene in the picture. Drug and Alcohol Review, 28, 616–622.
Trujols, J., Siñol, N., Iraurgi, I., Batlle, F., Guàrdia, J., & Pérez de los Cobos, J. (2011). Patient and clinician’s ratings of improvement in methadone-maintained patients: Differing perspectives? Harm Reduction Journal, 8, 23.
Trujols, J., Iraurgi, I., Oviedo-Joekes, E., & Guardia-Olmos, J. (2014). A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study. Patient Preference and Adherence, 8, 107–117.
Vander Laenen, F. (2009). ‘I don’t trust you, you are going to tell.’ Adolescents with emotional and behavioural disorders participating in qualitative research. H Child: Care, Health and Development, 35, 323–329.
Vander Laenen, F. (2015). Not just another focus group: making the case for the nominal group technique in criminology. Crime Science, 4, 5.
Vander Laenen, F., Vandam L., & Colman, C. (2010). Met velen aan de tafel: goede voorbeelden van een integraal en geïntegreerd drugbeleid. Verslaving, 6, 54–71.
Vanderplasschen, W., Naert, J., Vander Laenen, F., & De Maeyer, J. (2015). Treatment satisfaction and quality of support in outpatient substitution treatment: opiate users’ experiences and perspectives. Drugs: Education, Prevention and Policy, 22, 272–280.
Vickerman, P., Martin, N., Turner, K., & Hickman, M. (2012). Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in HCV prevalence? Model projections for different epidemic settings. Addiction, 107, 1984–1995.
VVBV (2013). Registratie 2013. Drughulpverlening Vlaanderen. Gent: VVBV. http://www.verslaafdenzorg.be/images/pdf/VVBVrapport2013.pdf. Zugegeiffen: 10. Okt. 2015.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vander Laenen, F., Favril, L. & Decorte, T. Prioriteiten voor het lokale ‘harm reduction’-beleid. Verslaving 12, 106–120 (2016). https://doi.org/10.1007/s12501-015-0047-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12501-015-0047-5